Call Options

27 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $1.55 Million - $1.89 Million
-13,000 Reduced 3.24%
388,400 $46.2 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $4.07 Million - $4.88 Million
33,200 Added 9.02%
401,400 $57.3 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $18.8 Million - $25 Million
184,100 Added 100.0%
368,200 $47.3 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $11.3 Million - $13.5 Million
-128,400 Reduced 41.09%
184,100 $19 Million
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $23 Million - $50.4 Million
252,600 Added 421.7%
312,500 $28.4 Million
Q2 2023

Aug 23, 2023

BUY
$155.98 - $172.65 $5.05 Million - $5.59 Million
32,400 Added 117.82%
59,900 $9.69 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $13,234 - $15,913
-100 Reduced 0.36%
27,500 $4.35 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $461,475 - $608,985
-4,500 Reduced 14.02%
27,600 $3.74 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $3.06 Million - $3.75 Million
32,100 New
32,100 $3.22 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $1.28 Million - $1.51 Million
-12,400 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $7.35 Million - $8.88 Million
-78,900 Reduced 86.42%
12,400 $1.4 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $5.09 Million - $6.22 Million
53,100 Added 139.01%
91,300 $10.2 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $1.9 Million - $2.4 Million
22,500 Added 143.31%
38,200 $3.67 Million
Q2 2021

Aug 06, 2021

BUY
$67.66 - $84.76 $487,152 - $610,272
7,200 Added 84.71%
15,700 $1.32 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $570,010 - $644,470
8,500 New
8,500 $577,000
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $2.06 Million - $2.27 Million
-32,300 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $1.89 Million - $2.19 Million
32,300 New
32,300 $2.12 Million
Q1 2020

May 11, 2020

SELL
$49.46 - $64.78 $1.82 Million - $2.38 Million
-36,700 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$49.86 - $58.26 $274,230 - $320,430
5,500 Added 17.63%
36,700 $2.12 Million
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $651,298 - $731,991
13,700 Added 78.29%
31,200 $1.61 Million
Q2 2019

Aug 20, 2019

BUY
$46.79 - $52.47 $210,555 - $236,115
4,500 Added 34.62%
17,500 $893,000
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $653,676 - $742,083
-14,100 Reduced 52.03%
13,000 $680,000
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $531,712 - $604,800
-12,800 Reduced 32.08%
27,100 $1.24 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $1.38 Million - $1.52 Million
29,600 Added 287.38%
39,900 $1.88 Million
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $499,447 - $598,842
10,300 New
10,300 $507,000
Q4 2017

Feb 14, 2018

SELL
$47.53 - $53.73 $841,281 - $951,021
-17,700 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$41.15 - $49.22 $728,355 - $871,194
17,700
17,700 $852,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.